KUALA LUMPUR, Sept 12 -- Atomwise Inc and Hansoh Pharmaceutical Group Company Limited (Hansoh Pharma) have collaborated to design and discover potential drug candidates.
In a statement, Atomwise, an artificial intelligence (AI) for drug discovery leader said the discovery involved up to 11 undisclosed target proteins in multiple therapeutic areas.
Scientific teams from both Atomwise and the China-based Hansoh Pharma will work closely on the programmes.
The combination of complementary expertise and technologies has the potential to dramatically increase success and compress timelines for drug discovery and clinical development.
Under the terms of the collaboration, Atomwise will receive undisclosed technology access fees, option exercise fees, royalties and income based on sub-licensing or sale of assets created under the collaboration.
Meanwhile, Hansoh Pharma will receive rights for development and commercialisation in all fields and geographies.
-- BERNAMA
No comments:
Post a Comment